Adsorption of 5-aminosalicylic acid on kaolinite surfaces at a molecular level

被引:5
作者
Awad, Mahmoud E. [1 ,2 ,3 ]
Escamilla-Roa, Elizabeth [3 ,4 ]
Borrego-Sanchez, Ana [2 ,3 ]
Viseras, Cesar [2 ,3 ]
Hernandez-Laguna, Alfonso [3 ]
Ignacio Sainz-Diaz, C. [3 ]
机构
[1] Al Azhar Univ Cairo, Fac Sci, Dept Geol, Nasr City 11884, Egypt
[2] Univ Granada, Sch Pharm, Dept Pharm & Pharmaceut Technol, Granada 18071, Spain
[3] CSIC, UGR, Inst Andaluz Ciencias Tierra, Av Las Palmeras 4, Granada 18100, Spain
[4] Lulea Univ Technol, Dept Comp Sci Elect & Space Engn, S-97187 Lulea, Sweden
关键词
kaolinite; 5-aminosalicylic acid; mesalazine; adsorption; surface; molecular modelling; atomistic calculations; pharmaceutical carrier; MONTMORILLONITE; IMPROVEMENT; KINETICS; PEPTIDE; METHANE; VALUES; DFT; CO2;
D O I
10.1180/clm.2019.13
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
The application of clay minerals in therapeutics is becoming important due to their structural and surface physicochemical properties. 5-aminosalicylic acid (5-ASA) is a very common pharmaceutical drug and is used worldwide. The interactions between the 5-ASA molecule and both the aluminol and siloxane surfaces of kaolinite are studied by means of atomistic calculations using force fields based on empirical interatomic potentials and quantum mechanics calculations based on density functional theory. A conformational analysis of 5-ASA has been performed and the anion of 5-ASA was also studied. The calculated adsorption energy values indicate that 5-ASA is likely to be adsorbed on the kaolinite surfaces with greater affinity to the aluminol surface. Hence, kaolinite may be considered as a promising pharmaceutical carrier of 5-ASA.
引用
收藏
页码:49 / 56
页数:8
相关论文
共 50 条
  • [41] Glyphosate adsorption onto kaolinite and kaolinite-humic acid composites: Experimental and molecular dynamics studies
    Guo, Fayang
    Zhou, Min
    Xu, Jingcheng
    Fein, Jeremy B.
    Yu, Qiang
    Wang, Yingwei
    Huang, Qiaoyun
    Rong, Xingmin
    CHEMOSPHERE, 2021, 263
  • [42] Validation of a LC method for the determination of 5-aminosalicylic acid and its metabolite in plasma and urine
    Bystrowska, B
    Nowak, J
    Brandys, J
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2000, 22 (02) : 341 - 347
  • [43] 5-Aminosalicylic acid inhibits TGF-β1 signalling in colorectal cancer cells
    Koelink, Pim J.
    Hawinkels, Lukas J. A. C.
    Wiercinska, Eliza
    Sier, Cornelis F. M.
    ten Dijke, Peter
    Lamers, Cornelis B. H. W.
    Hommes, Daan W.
    Verspaget, Hein W.
    CANCER LETTERS, 2010, 287 (01) : 82 - 90
  • [44] Adsorption of Nitrate on Kaolinite Surfaces: A Theoretical Study
    Tribe, Lorena
    Hinrichs, Ryan
    Kubicki, James D.
    JOURNAL OF PHYSICAL CHEMISTRY B, 2012, 116 (36) : 11266 - 11273
  • [45] Comparative cytotoxicity of 5-aminosalicylic acid (mesalazine) and related compounds in different cell lines
    E. Noble
    L. Janssen
    P.J. Dierickx
    Cell Biology and Toxicology, 1997, 13 : 445 - 451
  • [46] Factors associated with low adherence to oral 5-aminosalicylic acid in patients with ulcerative colitis
    Lee, Jin
    Jee, Sam Ryong
    Kim, Hyung Wook
    Baek, Dong Hoon
    Song, Geun Am
    Moon, Won
    Park, Seun Ja
    Kim, Hyun Jin
    Lee, Jong Hoon
    Park, Jong Ha
    Kim, Tae Oh
    PLOS ONE, 2019, 14 (03):
  • [47] Comparative cytotoxicity of 5-aminosalicylic acid (mesalazine) and related compounds in different cell lines
    Noble, E
    Janssen, L
    Dierickx, PJ
    CELL BIOLOGY AND TOXICOLOGY, 1997, 13 (06) : 445 - 451
  • [48] RETROGRADE DISTRIBUTION OF A NEW 5-AMINOSALICYLIC ACID ENEMA IN PATIENTS WITH ULCERATIVE-COLITIS
    ALMER, S
    EKBERG, S
    STROM, M
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1992, 16 (6-7): : 564 - 568
  • [49] A dynamic model of once-daily 5-aminosalicylic acid predicts clinical efficacy
    Deepak Parakkal
    Eli D Ehrenpreis
    Matthew P Thorpe
    Karson S Putt
    Bruce Hannon
    World Journal of Gastroenterology, 2010, 16 (01) : 136 - 137
  • [50] Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease -: A systematic review
    Gisbert, JP
    Gomollón, F
    Maté, J
    Pajares, JM
    DIGESTIVE DISEASES AND SCIENCES, 2002, 47 (03) : 471 - 488